Safety and Efficacy of Conestat Alfa for ACE-Induced Angioedema

Clinical trial NCT06679426 · UNKNOWN

Trial details

NCT number: NCT06679426
Sponsor: University of Cincinnati
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

ACE Inhibitor-Induced Angioedema

Start date: 2024-12-01
Primary completion: 2025-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.